# Observational leukemia studies recruiting: 230 (2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 230 trials that are observational for leukemia that are recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Recruiting observational leukemia studies: 230 rows for $11.50, recruiting or not yet recruiting on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. The new rows each week by email, about 4 rows a month: $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/recruiting/observational/leukemia

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 230
- Recruiting or not yet: 230
- Read on: November 19, 2026

## Trials

The 25 newest of 230, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| November 18, 2026 | NCT07945236 | FISH Detection of PML::RARA and BCR::ABL1 | Assiut University | Observational | Not yet recruiting | Acute Promyelocytic Leukemia, Chronic Myeloid Leukemia | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07945236) |
| November 5, 2026 | NCT07919119 | Risk Stratification Value of Deep NGS-MRD Detection in Acute Myeloid Leukemia Patients After Allo-HSCT | Institute of Hematology & Blood Diseases Hospital, China | Observational | Not yet recruiting | Measurable Residual Disease, Acute Myeloid Leukemia | 169 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07919119) |
| October 27, 2026 | NCT07898488 | Glycemic Control in Leukemia Patients | Assiut University | Observational | Not yet recruiting | Leukemia | 54 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07898488) |
| October 27, 2026 | NCT07898436 | Menin Inhibitors in Pediatric Relapsed or Refractory Acute Leukemia | University Hospital, Strasbourg, France | Observational | Recruiting | Acute Leukemia, Relapsed or Refractory Pediatric Leukemia, KMT2A-rearranged, NUP98-rearranged, or NPM1-mutated... | 10 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07898436) |
| October 26, 2026 | NCT07895901 | Characterization of CD180 Protein Expression in Myeloid Hematological Malignancies by Flow Cytometry | University Hospital, Strasbourg, France | Observational | Recruiting | Acute Myeloid Leukemia, Myeloid Hematological Malignancies, Normal Hematopoietic Stem and Progenitor Cells | 50 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07895901) |
| October 20, 2026 | NCT07882732 | RPM Signals in Outpatient CAR T Therapy | Current Health | Observational | Not yet recruiting | Cytokine Release Syndrome, Immune Effector Cell-Associated Neurotoxicity Syndrome, B-Cell Lymphoma, Chronic Lymphocytic... | 125 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07882732) |
| September 9, 2026 | NCT07810829 | Prognostic Value of CAR, AFR and Ferritin in Non-M3 AML | Assiut University | Observational | Not yet recruiting | Acute Myeloid Leukemia, Non-M3 Acute Myeloid Leukemia, De Novo Acute Myeloid Leukemia With Multilineage Dysplasia | 208 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07810829) |
| September 3, 2026 | NCT07802015 | Home-based Intravenous Cytarabine Treatment for Acute Myeloid Leukemia: a National Danish Study of Feasibility, Costs, and Implementation | Zealand University Hospital | Observational | Not yet recruiting | Hematologic Cancer, Acute Myeloid Leukaemia (AML), Hospital At Home, Home-based Chemotherapy | 80 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07802015) |
| August 25, 2026 | NCT07785505 | Musculoskeletal Ultrasound in Patients With Hematologic Malignancies | Assiut University | Observational | Not yet recruiting | Hematologic Neoplasms, Leukemia, Lymphoma, Multiple Myeloma, Musculoskeletal Diseases | 50 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07785505) |
| August 19, 2026 | NCT07774390 | Ibrutinib Plus Venetoclax Long-Term Outcomes in CLL | European Research Initiative on CLL | Observational | Recruiting | Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL) | 323 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07774390) |
| August 13, 2026 | NCT07763054 | Low-dose Liposomal Amphotericin B for Antifungal Prophylaxis in Prolonged Neutropenia Patients | Haikou Affiliated Hospital of Central South University Xiangya School of Medicine | Observational | Recruiting | Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndrome, Lymphoma, Multiple Myeloma, Chronic... | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07763054) |
| August 12, 2026 | NCT07759661 | Innovative 3D Preclinical Models for Mature B-cell Malignancies to Advance Personalized Immuno and Combination Therapies | IRCCS San Raffaele | Observational | Not yet recruiting | Chronic Lymphocytic Leukemia (CLL), Splenic Marginal Zone Lymphoma, Hairy Cell Leukemia (HCL) | 64 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07759661) |
| August 7, 2026 | NCT07751588 | Plasma ctDNA Monitoring in Pediatric Acute Leukemia | Institute of Hematology & Blood Diseases Hospital, China | Observational | Not yet recruiting | Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia | 25 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07751588) |
| August 3, 2026 | NCT07743047 | Harnessing the Immunosuppressive Leukemic Microenvironment to Engineer T Cells With Enhanced Anti-tumor Functionality | IRCCS San Raffaele | Observational | Not yet recruiting | Acute Myeloid Leukemia | 65 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07743047) |
| August 3, 2026 | NCT07741695 | Targeting IRAK4 in Chronic Lymphocytic Leukemia | IRCCS San Raffaele | Observational | Not yet recruiting | Chronic Lymphocytic Leukemia (CLL) | 50 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07741695) |
| July 31, 2026 | NCT07740603 | Study of CD38 and CD56 in Chronic Myeloid Leukemia | Sohag University | Observational | Not yet recruiting | Chronic Myeloid Leukemia (CML) | 200 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07740603) |
| July 27, 2026 | NCT07727083 | Clinical and Biological Cohort Study of EBV-Positive T/NK-Cell Lymphoproliferative Diseases | Sponsor not shown (see the record) | Observational | Recruiting | Extranodal NK/T-cell Lymphoma, Aggressive NK-Cell Leukemia, Systemic Chronic Active Epstein-Barr Virus Disease... | 1,500 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07727083) |
| July 21, 2026 | NCT07717164 | PRAISE-IR Versus CIBMTR Controls | Miltenyi Biomedicine GmbH | Observational | Not yet recruiting | ALL (Acute B-Lymphoblastic Leukemia), AML (Acute Myeloid Leukemia), MDS (Myelodysplastic Syndrome) | 51 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07717164) |
| July 20, 2026 | NCT07714044 | Rutgers University Study of the Genetics of Blood Cancers | Rutgers, The State University of New Jersey | Observational | Recruiting | Blood Cancers, Blood Cancer, Leukemia, Lymphoma, Myeloma, Hematologic Cancer, Hematologic Malignancies, Hematologic... | 10,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07714044) |
| July 17, 2026 | NCT07711327 | Atrial Fibrillation Among Patients With Hematologic Malignancies on Tyrosine Kinase Inhibitor Therapy | Sponsor not shown (see the record) | Observational | Not yet recruiting | Atrial Fibrillation (AF), Chronic Lymphocytic Leukemia, Waldenstrom Macroglobulinemia, Mantle Cell Lymphoma, Marginal... | 500 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07711327) |
| July 2, 2026 | NCT07681258 | A Study of Asciminib Safety and Efficacy in Young Adults With Chronic Myeloid Leukemia in the Gulf Region | Novartis Pharmaceuticals | Observational | Not yet recruiting | Chronic Myeloid Leukemia | 80 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07681258) |
| July 2, 2026 | NCT07680868 | Caris Chromoseq Data Collection | Caris Science, Inc. | Observational | Recruiting | Acute Myeloid Leukemia (AML), Myelodysplastic (MDS) / Myeloproliferative (MPN) Diseases, Myelodysplatic Syndromes... | 300 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07680868) |
| June 26, 2026 | NCT07670130 | Venetoclax TDM in Newly Diagnosed AML: Exposure-Response and Prognosis | The First Affiliated Hospital of Soochow University | Observational | Recruiting | Acute Myeloid Leukemia (AML) | 50 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07670130) |
| June 11, 2026 | NCT07640750 | Efficacy of Asciminib in Real-world in Patients With Chronic Myeloid Leukemia in Second or Subsequent Lines | Gruppo Italiano Malattie EMatologiche dell'Adulto | Observational | Not yet recruiting | Chronic Myeloid Leukemia, Chronic Myeloid Leukemia - Chronic Phase | 98 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07640750) |
| June 10, 2026 | NCT07638007 | Impact of Targeted Therapy on Cancer-Related Cognitive Impairment | University of Rochester NCORP Research Base | Observational | Recruiting | Disease/Condition Name Cancer-related Cognitive Dysfunction, Chronic Lymphocytic Leukemia (CLL), Chronic Myeloid... | 400 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07638007) |

## Sponsors with the most

| Sponsor | Trials |
| --- | --- |
| Assiut University | 12 |
| Peking University People's Hospital | 6 |
| Assistance Publique - Hôpitaux de Paris | 6 |
| National Cancer Institute (NCI) | 6 |
| IRCCS Azienda Ospedaliero-Universitaria di Bologna | 6 |
| [Novartis Pharmaceuticals](https://specstream.ai/data/clinical-trials/company/novartis-pharmaceuticals) | 5 |
| Gruppo Italiano Malattie EMatologiche dell'Adulto | 4 |
| [AstraZeneca](https://specstream.ai/data/clinical-trials/company/astrazeneca) | 4 |
| University Health Network, Toronto | 4 |
| Mayo Clinic | 4 |
| Wake Forest University Health Sciences | 4 |
| Institute of Hematology & Blood Diseases Hospital, China | 4 |
| Dana-Farber Cancer Institute | 4 |
| Ruijin Hospital | 3 |
| UNC Lineberger Comprehensive Cancer Center | 3 |
| Children's Oncology Group | 3 |
| Nantes University Hospital | 3 |
| IRCCS San Raffaele | 3 |
| [iOMEDICO AG](https://specstream.ai/data/clinical-trials/company/iomedico-ag) | 2 |
| [Pfizer](https://specstream.ai/data/clinical-trials/company/pfizer) | 2 |
| M.D. Anderson Cancer Center | 2 |
| Memorial Sloan Kettering Cancer Center | 2 |
| Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia | 2 |
| University Hospital, Clermont-Ferrand | 2 |
| Munich Leukemia Laboratory | 2 |

## By country

| Country | Trials |
| --- | --- |
| United States | 73 |
| France | 28 |
| Italy | 24 |
| China | 21 |
| Germany | 17 |
| Canada | 8 |
| Austria | 7 |
| Spain | 6 |
| Australia | 5 |
| United Kingdom | 5 |
| Switzerland | 5 |
| Denmark | 4 |
| Belgium | 4 |
| Czechia | 4 |
| Puerto Rico | 3 |
| Lithuania | 3 |
| Netherlands | 3 |
| Greece | 3 |
| South Korea | 3 |
| Hungary | 2 |
| Norway | 2 |
| Sweden | 2 |
| Egypt | 2 |
| Japan | 2 |
| Romania | 2 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Animation studios in the United States](https://specstream.ai/data/businesses/animation-studios/united-states)
- [Office cleaning companies in the United States](https://specstream.ai/data/businesses/office-cleaning-companies/united-states)
- [Dental hygiene clinics in the United States](https://specstream.ai/data/businesses/dental-hygiene-clinics/united-states)
- [Telephone service providers in the United States](https://specstream.ai/data/businesses/telephone-service-providers/united-states)
- [Internet service providers in the United States](https://specstream.ai/data/businesses/internet-service-providers/united-states)
- [Biotechnology companies in the United States](https://specstream.ai/data/businesses/biotechnology-companies/united-states)
